One possible molecular target is the vascular endothelial growth factor receptor 1 (VEGFR1), a receptor tyrosine kinase that binds various VEGF and placental growth factors to promote migration and survival of hematopoietic stem cells and leukemia cells [66]. Here, FLT1 is linked to leukemia.